Global Nicotine Addiction Treatment Market Industry Outlook 2026||ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences, Inc, Cerecor, Inc

An international Nicotine Addiction Treatment business report offers marketing and business managers a platform to obtain critical information about their consumers so that existing customers can be retained and new ones can be got onboard. The market report helps in understanding customer inclination towards purchasing products. It also provides the details such as whether the customers will spend a certain amount of money for their products, inclination levels among customers about upcoming features or products, what are their thoughts about the competitor products etc. Data gathered using Nicotine Addiction Treatment market report is instrumental in making major changes in the business which reduces the degree of risks involved in taking important business decisions.

Global nicotine addiction treatment market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Government policies and initiatives to offer a fund to many research institute and pharmaceuticals companies for developing novel therapy and increase dependency of tobacco products are the key factors for market growth.

Ask For Complimentary Sample PDF| Request At of the major competitors currently working in the global nicotine addiction treatment market are Hager Biosciences, LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences, Inc, Cerecor, Inc, Astraea Therapeutics LLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Pfizer Inc, Novartis AG, Sanofi, Dr. Reddy’s Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Mylan N.V. , Axsome Therapeutics, Inc. and others.

Market Drivers

High prevalence of tobacco products consumptions acts as a market driver

Vulnerable adult population as adults are at high risk for nicotine addiction also drives the market growth

Increase in government initiatives and polices can also act as a market driver

Rapid adoption of newer formulations and novel dosage forms can boost the market growth

Market Restraints

Limited success of existing smoking cessation methods is also hampering the market growth

Preference of non-pharmacology therapies over pharmacology therapies can hinder the market growth

Patent expiry of major drugs and introduction of generic drugs of branded version is expected to restrict the growth of this market

Key Developments in the Market:

In June 2018, Omeros Corporation received approval from regulatory authority and ethics committee to initiate phase I clinical trial for its lead candidate PDE7, phosphodiesterase inhibitor for the treatment of all addictions including nicotine addiction and compulsive disorders. If successful, it will represent an immense and urgent unmet need for the treatment of nicotine addiction

In December 2017, Axsome Therapeutics, Inc entered into research collaboration with Duke University to develop AXS-05, a novel, oral, fixed-dose combination of dextromethorphan and bupropion. Under the deal terms, Duke University will be responsible for conducting preclinical research. This strategic alliance significantly contributes in solving the problem of tobacco addiction worldwide

View detailed table of content here

Segmentation: Global Nicotine Addiction Treatment Market

By Type

  • Combustible Tobacco
  • Smokeless Tobacco

By Treatment Type

  • Nicotine Replacement Therapy
  • Psychological Therapy

By Drugs

  • Approved-Drugs
  • Nicotine
  • Varenicline
  • Bupropion Hydrochloride
  • Off-label Drugs
  • Clonidine
  • Topiramate
  • Naltrexone
  • Nortriptyline
  • Others

By Product Type

  • Patch
  • Gum
  • Pills
  • Lozenge
  • Spray
  • Others

By Route of Administration

  • Oral
  • Inhalation
  • Injectable

By Drug Delivery System

  • Transdermal Drug Delivery System
  • Buccal Drug Delivery System
  • Others

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Inquiry For Customize Report With Discount at :

Major Insights of the Report

  1. To describe and forecast the Nicotine Addiction Treatment market, in terms of value, by process, product type, and industry.
  2. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Nicotine Addiction Treatment Market
  3. The key findings and recommendations highlight crucial progressive industry trends in the Nicotine Addiction Treatment Market, thereby allowing players to develop effective long term strategies
  4. To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the Nicotine Addiction Treatment market
  5. The report offers market share appraisals for regional and global levels

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Back to top button